EAGLE PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was $5.16M.
  • Eagle Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was $11.9M, a 47.6% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $35.6M.
  • Eagle Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$8.63M, a 172% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was $12M, a 16.2% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $11.9M $5.16M +$14.6M Apr 1, 2023 Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 -$2.67M $5.75M -$38.3M -86.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $35.6M $8.17M +$14.4M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 $21.3M -$7.13M -$1.51M -26.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $22.8M -$9.45M -$13.1M -362% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-09
Q1 2022 $35.9M $44.1M +$44.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$8.63M -$6.2M -$14.3M -177% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $5.63M -$5.62M -$12.7M -180% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $18.3M $3.61M +$3.87M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $14.4M -$421K +$2.45M +85.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $12M $8.06M +$7.05M +702% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $4.94M $7.06M +$9.45M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$4.51M -$256K -$6.98M -104% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $2.47M -$2.87M -$11.8M -132% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $14.3M $1.01M -$11.6M -92% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 $25.9M -$2.39M -$16.4M -117% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $42.3M $6.73M +$4.07M +153% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $38.3M $8.97M +$6.36M +243% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $31.9M $12.6M +$3.5M +38.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-05
Q3 2018 $28.4M $14M -$1.39M -9.01% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $29.8M $2.66M -$1.84M -41% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $31.6M $2.62M -$20.3M -88.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $51.9M $9.09M -$48.2M -84.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $100M $15.4M +$3.48M +29.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $96.7M $4.5M -$8.6M -65.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $105M $22.9M +$23.8M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $81.5M $57.3M +$56.1M +4604% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $25.4M $12M +$22.1M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $3.25M $13.1M +$21.3M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$18M -$896K -$20.6M -105% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $2.57M $1.22M +$6.72M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 -$4.15M -$10.2M -$1.06M -11.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$3.09M -$8.18M -$5.24M -179% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $2.15M $19.7M +$22.4M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$20.2M -$5.51M -$2.25M -69.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$18M -$9.1M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.93M -$3.69M -489% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$2.68M +$2.12M +44.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$3.26M Oct 1, 2013 Dec 31, 2013 10-K 2017-03-15
Q2 2013 $755K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$4.8M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.